Apr. 5, 2018—Charlotte Haffner, Vanderbilt’s first patient to undergo a heart transplant followed by a stem cell transplant to treat a plasma cell disorder called primary AL amyloidosis, now she dedicates her time to raising awareness about the rare disease.
Dec. 1, 2017—Recent findings suggest that vitamin C deficiency could contribute to Alzheimer’s disease, suggesting that avoiding deficiency through diet and supplementation could protect against disease onset.
Apr. 27, 2017—A new protein structure may guide the development of Alzheimer's therapeutics.
Dec. 6, 2012—The Vanderbilt Amyloid Multidisciplinary Program (VAMP) is a new approach to treating a rare and misunderstood disease that can kill its victims before they understand what they have been diagnosed with.
May. 31, 2012—The molecular structure of a protein involved in Alzheimer’s disease – and the surprising discovery that it binds cholesterol – could lead to new therapeutics for the memory-robbing disease.